RVMD
NASDAQ · Biotechnology
Revolution Medicines Inc
$177.65
-22.05 (-11.04%)
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Price Target
Analyst Price Target
-35.8% upside
Low Target
$80.83
Average Target
$114.11
High Target
$120.13
Current Price
$177.65
Current
$177.65
$177.65
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Scenario Analysis
Bear Case
$80.83
-54.5%
Low target
Base Case
$114.11
-35.8%
Avg target
Bull Case
$120.13
+-32.4%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$224.31
-20.8% from high
52-Week Low
$56.66
+213.5% from low
50-Day SMA
$198.21
-10.4% vs SMA
200-Day SMA
$157.15
+13.0% vs SMA
RSI (14)
58.1
Neutral
Target vs 52W High
$114.11
-49.1% vs high
Next Earnings Report
Nov 11, 2026 · After Market Close
4d
until earnings
EPS Est: $-2.45
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |